Dupilumab cuts exacerbation rates in patients with asthma regardless of lung function
Patients with moderate-to-severe asthma had significant reductions in annualized severe asthma exacerbation rate with the monoclonal antibody dupilumab, regardless of lung function, according to a post hoc analysis of LIBERTY ASTHMA QUEST* presented at ERS 2020.
High LDL-C levels up incidence of cardiovascular events after PCI
Increased levels of low-density lipoprotein cholesterol (LDL-C) appear to boost the incidence of late cardiovascular events following percutaneous coronary intervention (PCI), a study has found.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in